VFM
BIIB icon

Viking Fund Management’s Biogen BIIB Stock Holding History

Viking Fund Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,350
Closed -$575K – 121
2020
Q4 		$575K Hold
2,350
– – 0.19% 109
2020
Q3 		$667K Hold
2,350
– – 0.25% 97
2020
Q2 		$629K Buy
2,350
+350
+18% +$105K 0.23% 104
2020
Q1 		$633K Hold
2,000
– – 0.28% 86
2019
Q4 		$593K Hold
2,000
– – 0.17% 98
2019
Q3 		$466K Hold
2,000
– – 0.13% 109
2019
Q2 		$468K Buy
2,000
+1,000
+100% +$231K 0.12% 107
2019
Q1 		$236K Hold
1,000
– – 0.06% 113
2018
Q4 		$301K Buy
+1,000
New +$319K 0.08% 114

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Viking Fund Management's BIIB Position: Q1 2021 in Review

Viking Fund Management sold out of Biogen (BIIB) in Q1 2021, closing a stake of 2,350 shares — an estimated $575K sold.

Viking Fund Management first reported a position in BIIB in Q4 2018 and held it in 9 quarters. The position peaked at $667K in Q3 2020. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Viking Fund Management reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Viking Fund Management sold 2,350 Biogen shares in Q1 2021, an estimated $575K.
  • Viking Fund Management first reported a position in Biogen in Q4 2018 and held it in 9 quarters.
  • Viking Fund Management's Biogen position peaked at $667K in Q3 2020.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Viking Fund Management's 13F filing for Q1 2021, filed 26 Apr 2021.